Skip to main content
Top
Published in: Digestive Diseases and Sciences 4/2009

01-04-2009 | Original Article

R0 Liver Resections for Primary Malignant Liver Tumors in the Noncirrhotic Liver: A Diagnosis-Related Analysis

Authors: Georgios C. Sotiropoulos, Maximilian Bockhorn, George Sgourakis, Eirini I. Brokalaki, Ernesto P. Molmenti, Markus Neuhäuser, Arnold Radtke, Jeremias Wohlschlaeger, Hideo A. Baba, Christoph E. Broelsch, Hauke Lang

Published in: Digestive Diseases and Sciences | Issue 4/2009

Login to get access

Abstract

Background Primary liver cancer constitutes an increasingly malignancy in the Western world and one of the leading causes of cancer-related deaths worldwide. The purpose of this study was to evaluate and compare long-term outcomes after R0 resections in noncirrhotic livers for hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC). Methods Between April 1998 and May 2006 a total of 102 patients with either ICC (n = 41, group 1) or HCC (n = 61, group 2) in the absence of cirrhosis underwent curative liver resection in our department. Demographic characteristics, operative details, perioperative complications, pathologic findings, tumor recurrence and survival were analyzed. Results Gender (P = 0.007), extent of liver resection (P = 0.036), additional surgical procedures (P < 0.001) and operative morbidity (P = 0.018) differed among the two groups. Following resection, after a median follow-up of 28 months, the calculated 5-year survival was 44% and 40% for ICC and HCC, respectively (P = 0.38). The corresponding recurrence-free survival was 25% for both ICC and HCC (P = 0.66). UICC stage was found to predict overall and recurrence-free survival in both types of tumors. Multifocality in the case of ICC, and tumor differentiation and vascular invasion in the case of HCC, were predictive factors for overall and recurrence-free survival, respectively. In multivariable analyses, vascular invasion for HCC was predictive for overall and recurrence-free survival, whereas in the case of ICC significant differences were detected in the recurrence analysis for multifocality and UICC stage. Conclusions R0 resections for both ICC and HCC result to similar long-term outcomes, which are characterized by good overall and acceptable recurrence-free survival rates.
Literature
3.
go back to reference Motola-Kuba D, Zamora-Valdes D, Uribe M, Mendez-Sanchez N (2006) Hepatocellular carcinoma. An overview. Ann Hepatol 5:16–24PubMed Motola-Kuba D, Zamora-Valdes D, Uribe M, Mendez-Sanchez N (2006) Hepatocellular carcinoma. An overview. Ann Hepatol 5:16–24PubMed
5.
go back to reference Liver Cancer Study Group of Japan (1990) Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment. Ann Surg 211:277–287 Liver Cancer Study Group of Japan (1990) Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment. Ann Surg 211:277–287
9.
go back to reference Washburn WK, Lewis WD, Jenkins RL (1995) Aggressive surgical resection for cholangiocarcinoma. Arch Surg 130:270–276PubMed Washburn WK, Lewis WD, Jenkins RL (1995) Aggressive surgical resection for cholangiocarcinoma. Arch Surg 130:270–276PubMed
11.
go back to reference Cherqui D, Tantawi B, Alon R, Piedbois P, Rahmouni A, Dhumeaux D et al (1995) Intrahepatic cholangiocarcinoma. Results of aggressive surgical management. Arch Surg 130:1073–1078PubMed Cherqui D, Tantawi B, Alon R, Piedbois P, Rahmouni A, Dhumeaux D et al (1995) Intrahepatic cholangiocarcinoma. Results of aggressive surgical management. Arch Surg 130:1073–1078PubMed
12.
go back to reference Lang H, Sotiropoulos GC, Frühauf NR, Dömland M, Paul A, Kind EM et al (2005) Extended hepatectomy for intrahepatic cholangiocellular carcinoma (ICC): when is it worthwhile? Single center experience with 27 resections in 50 patients over a 5-year period. Ann Surg 241:134–143PubMed Lang H, Sotiropoulos GC, Frühauf NR, Dömland M, Paul A, Kind EM et al (2005) Extended hepatectomy for intrahepatic cholangiocellular carcinoma (ICC): when is it worthwhile? Single center experience with 27 resections in 50 patients over a 5-year period. Ann Surg 241:134–143PubMed
13.
go back to reference Belghiti J, Regimbeau JM, Durand F, Kianmanesh AR, Dondero F, Terris B et al (2002) Resection of hepatocellular carcinoma: a European experience on 328 cases. Hepatogastroenterology 49:41–46PubMed Belghiti J, Regimbeau JM, Durand F, Kianmanesh AR, Dondero F, Terris B et al (2002) Resection of hepatocellular carcinoma: a European experience on 328 cases. Hepatogastroenterology 49:41–46PubMed
14.
go back to reference Ko S, Nakajima Y, Kanehiro H, Hisanaga M, Aomatsu Y, Kin T et al (1996) Significant influence of accompanying chronic hepatitis status on recurrence of hepatocellular carcinoma after hepatectomy—results of multivariate analysis. Ann Surg 224:591–595. doi:10.1097/00000658-199611000-00001 PubMedCrossRef Ko S, Nakajima Y, Kanehiro H, Hisanaga M, Aomatsu Y, Kin T et al (1996) Significant influence of accompanying chronic hepatitis status on recurrence of hepatocellular carcinoma after hepatectomy—results of multivariate analysis. Ann Surg 224:591–595. doi:10.​1097/​00000658-199611000-00001 PubMedCrossRef
15.
go back to reference Llovet JM, Bustamante J, Castells A, Vilana R, Ayuso Mdel C, Sala M et al (1999) Natural history of untreated nonsurgical hepatocellular carcinoma: rational for the design and evaluation of therapeutic trials. Hepatology 29:62–67. doi:10.1002/hep.510290145 PubMedCrossRef Llovet JM, Bustamante J, Castells A, Vilana R, Ayuso Mdel C, Sala M et al (1999) Natural history of untreated nonsurgical hepatocellular carcinoma: rational for the design and evaluation of therapeutic trials. Hepatology 29:62–67. doi:10.​1002/​hep.​510290145 PubMedCrossRef
18.
go back to reference Lang H, Sotiropoulos GC, Brokalaki EI, Schmitz KJ, Bertona C, Meyer G et al (2007) Survival and recurrence rates after resection for hepatocellular carcinoma in noncirrhotic livers. J Am Coll Surg 205:27–36PubMedCrossRef Lang H, Sotiropoulos GC, Brokalaki EI, Schmitz KJ, Bertona C, Meyer G et al (2007) Survival and recurrence rates after resection for hepatocellular carcinoma in noncirrhotic livers. J Am Coll Surg 205:27–36PubMedCrossRef
Metadata
Title
R0 Liver Resections for Primary Malignant Liver Tumors in the Noncirrhotic Liver: A Diagnosis-Related Analysis
Authors
Georgios C. Sotiropoulos
Maximilian Bockhorn
George Sgourakis
Eirini I. Brokalaki
Ernesto P. Molmenti
Markus Neuhäuser
Arnold Radtke
Jeremias Wohlschlaeger
Hideo A. Baba
Christoph E. Broelsch
Hauke Lang
Publication date
01-04-2009
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 4/2009
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-008-0408-6

Other articles of this Issue 4/2009

Digestive Diseases and Sciences 4/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.